Hindustan Organic Chemicals Share Price
Sector: Chemical Manufacturing
36.52 +0.01 (0.03%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
36.52
Today’s High
36.53
52 Week Low
22.36
52 Week High
62.70
Key Metrics
- Market Cap (In Cr) 245.32
- Beta 1.66
- Div. Yield (%) 0
- P/B 0.23
- TTM P/E 0.73
- Peg Ratio -
- Sector P/E 18.02
- D/E 0
- Open Price 36.52
- Prev Close 36.51
Hindustan Organic Chemicals Analysis
Price Analysis
-
1 Week-1.27%
-
3 Months-6.17%
-
6 Month-11.28%
-
YTD-10.8%
-
1 Year-23.22%
Risk Meter
- 67% Low risk
- 67% Moderate risk
- 67% Balanced Risk
- 67% High risk
- 67% Extreme risk
Hindustan Organic Chemicals News
Q4 results today: LIC, Info Edge, Minda Corp, Supriya Lifesciences, Bosch, more
2 min read . 27 May 2025Small-cap stock under ₹50 rallies 20% as govt waives off ₹1,351 cr dues
1 min read . 24 Mar 2025Hindustan Organic Chemicals Q3 FY24 Results Live: Loss Rises by 31.79% YoY
1 min read . 11 Feb 2024Hindustan Organic Chemicals Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 535.87
- Selling/ General/ Admin Expenses Total
- 47.45
- Depreciation/ Amortization
- 1.64
- Other Operating Expenses Total
- 43.84
- Total Operating Expense
- 120.89
- Operating Income
- 414.98
- Net Income Before Taxes
- 394.87
- Net Income
- 391.78
- Diluted Normalized EPS
- 9.61
- Period
- 2025
- Total Assets
- 1564.37
- Total Liabilities
- 519.03
- Total Equity
- 1045.34
- Tangible Book Valueper Share Common Eq
- 155.59
- Period
- 2025
- Cashfrom Operating Activities
- 631.4
- Cashfrom Investing Activities
- 10.23
- Cashfrom Financing Activities
- -642.18
- Net Changein Cash
- -0.54
- Period
- 2024
- Total Revenue
- 703.89
- Selling/ General/ Admin Expenses Total
- 190.2
- Depreciation/ Amortization
- 1.42
- Other Operating Expenses Total
- 0.71
- Total Operating Expense
- 705.12
- Operating Income
- -1.23
- Net Income Before Taxes
- -55.32
- Net Income
- -54.62
- Diluted Normalized EPS
- -8.31
- Period
- 2024
- Total Assets
- 1572.34
- Total Liabilities
- 1623.78
- Total Equity
- -51.43
- Tangible Book Valueper Share Common Eq
- -7.68
- Period
- 2024
- Cashfrom Operating Activities
- -65.7
- Cashfrom Investing Activities
- 56.02
- Cashfrom Financing Activities
- 5.76
- Net Changein Cash
- -3.91
- Period
- 2023
- Total Revenue
- 631.44
- Selling/ General/ Admin Expenses Total
- 168.65
- Depreciation/ Amortization
- 1.17
- Other Operating Expenses Total
- 0.26
- Total Operating Expense
- 624.97
- Operating Income
- 6.47
- Net Income Before Taxes
- -50.86
- Net Income
- -53.39
- Diluted Normalized EPS
- -7.28
- Period
- 2023
- Total Assets
- 1474.18
- Total Liabilities
- 1524.45
- Total Equity
- -50.27
- Tangible Book Valueper Share Common Eq
- -7.51
- Period
- 2023
- Cashfrom Operating Activities
- -27.87
- Cashfrom Investing Activities
- 24.24
- Cashfrom Financing Activities
- -10.8
- Net Changein Cash
- -14.43
- Period
- 2022
- Total Revenue
- 433.68
- Selling/ General/ Admin Expenses Total
- 53.9
- Depreciation/ Amortization
- 1.14
- Other Operating Expenses Total
- 1.28
- Total Operating Expense
- 411.78
- Operating Income
- 21.9
- Net Income Before Taxes
- -32.32
- Net Income
- -29.65
- Diluted Normalized EPS
- -4.41
- Period
- 2022
- Total Assets
- 1475.04
- Total Liabilities
- 1479.81
- Total Equity
- -4.77
- Tangible Book Valueper Share Common Eq
- -0.75
- Period
- 2022
- Cashfrom Operating Activities
- 9.93
- Cashfrom Investing Activities
- 10.62
- Cashfrom Financing Activities
- -31.9
- Net Changein Cash
- -11.35
- Period
- 2021
- Total Revenue
- 415.25
- Selling/ General/ Admin Expenses Total
- 166.95
- Depreciation/ Amortization
- 2.9
- Other Operating Expenses Total
- 2.04
- Total Operating Expense
- 390.82
- Operating Income
- 24.43
- Net Income Before Taxes
- -8.29
- Net Income
- 2.53
- Diluted Normalized EPS
- 0.36
- Period
- 2021
- Total Assets
- 1440.44
- Total Liabilities
- 1409.5
- Total Equity
- 30.94
- Tangible Book Valueper Share Common Eq
- 4.57
- Period
- 2021
- Cashfrom Operating Activities
- -49.7
- Cashfrom Investing Activities
- 7.52
- Cashfrom Financing Activities
- 51.55
- Net Changein Cash
- 9.37
- Period
- 2020
- Total Revenue
- 331.34
- Selling/ General/ Admin Expenses Total
- 109.98
- Depreciation/ Amortization
- 2.7
- Other Operating Expenses Total
- 2.42
- Total Operating Expense
- 391.87
- Operating Income
- -60.54
- Net Income Before Taxes
- -97.81
- Net Income
- -96.23
- Diluted Normalized EPS
- -14.49
- Period
- 2020
- Total Assets
- 1374.2
- Total Liabilities
- 1356.84
- Total Equity
- 17.36
- Tangible Book Valueper Share Common Eq
- 2.3
- Period
- 2020
- Cashfrom Operating Activities
- -143.08
- Cashfrom Investing Activities
- 163.05
- Cashfrom Financing Activities
- -27.61
- Net Changein Cash
- -7.64
- Period
- 2019
- Total Revenue
- 510.85
- Selling/ General/ Admin Expenses Total
- 93.14
- Depreciation/ Amortization
- 3.26
- Other Operating Expenses Total
- 11.8
- Total Operating Expense
- 485.32
- Operating Income
- 25.53
- Net Income Before Taxes
- 73.22
- Net Income
- 72.48
- Diluted Normalized EPS
- 5.68
- Period
- 2019
- Total Assets
- 1551
- Total Liabilities
- 1440.23
- Total Equity
- 110.77
- Tangible Book Valueper Share Common Eq
- 16.22
- Period
- 2019
- Cashfrom Operating Activities
- -160.41
- Cashfrom Investing Activities
- 111.97
- Cashfrom Financing Activities
- 3.29
- Net Changein Cash
- -45.15
- Period
- 2025-03-31
- Total Revenue
- 136.62
- Selling/ General/ Admin Expenses Total
- 12.92
- Depreciation/ Amortization
- 0.35
- Other Operating Expenses Total
- 16.49
- Total Operating Expense
- -371.52
- Operating Income
- 508.14
- Net Income Before Taxes
- 523.01
- Net Income
- 519.82
- Diluted Normalized EPS
- 24.58
- Period
- 2025-03-31
- Total Assets
- 1564.37
- Total Liabilities
- 519.03
- Total Equity
- 1045.34
- Tangible Book Valueper Share Common Eq
- 155.59
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 631.4
- Cashfrom Investing Activities
- 10.23
- Cashfrom Financing Activities
- -642.18
- Net Changein Cash
- -0.54
- Period
- 2024-12-31
- Total Revenue
- 165.16
- Selling/ General/ Admin Expenses Total
- 11.14
- Depreciation/ Amortization
- 0.46
- Other Operating Expenses Total
- 8.2
- Total Operating Expense
- 234.01
- Operating Income
- -68.85
- Net Income Before Taxes
- -78.77
- Net Income
- -78.99
- Diluted Normalized EPS
- -5.38
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 174.72
- Selling/ General/ Admin Expenses Total
- 11.42
- Depreciation/ Amortization
- 0.45
- Other Operating Expenses Total
- 9.36
- Total Operating Expense
- 175.13
- Operating Income
- -0.41
- Net Income Before Taxes
- -13.8
- Net Income
- -13.64
- Diluted Normalized EPS
- -2.06
- Period
- 2024-09-30
- Total Assets
- 1577.8
- Total Liabilities
- 1675.55
- Total Equity
- -97.75
- Tangible Book Valueper Share Common Eq
- -14.57
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -30.53
- Cashfrom Investing Activities
- 0.46
- Cashfrom Financing Activities
- 29.87
- Net Changein Cash
- -0.19
- Period
- 2024-06-30
- Total Revenue
- 59.36
- Selling/ General/ Admin Expenses Total
- 11.97
- Depreciation/ Amortization
- 0.38
- Other Operating Expenses Total
- 9.79
- Total Operating Expense
- 83.26
- Operating Income
- -23.9
- Net Income Before Taxes
- -35.56
- Net Income
- -35.42
- Diluted Normalized EPS
- -5.31
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 182.87
- Selling/ General/ Admin Expenses Total
- 9.06
- Depreciation/ Amortization
- 0.39
- Other Operating Expenses Total
- 39.46
- Total Operating Expense
- 183.17
- Operating Income
- -0.3
- Net Income Before Taxes
- -12.96
- Net Income
- -11.91
- Diluted Normalized EPS
- -2
- Period
- 2024-03-31
- Total Assets
- 1572.34
- Total Liabilities
- 1623.78
- Total Equity
- -51.43
- Tangible Book Valueper Share Common Eq
- -7.68
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -65.7
- Cashfrom Investing Activities
- 56.02
- Cashfrom Financing Activities
- 5.76
- Net Changein Cash
- -3.91
- Period
- 2023-12-31
- Total Revenue
- 186.82
- Selling/ General/ Admin Expenses Total
- 12.09
- Depreciation/ Amortization
- 0.37
- Other Operating Expenses Total
- 8.44
- Total Operating Expense
- 190.51
- Operating Income
- -3.69
- Net Income Before Taxes
- -17.67
- Net Income
- -17.82
- Diluted Normalized EPS
- -2.63
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Hindustan Organic Chemicals Technical
Moving Average
SMA
- 5 Day35.93
- 10 Day36.87
- 20 Day36.15
- 50 Day36.41
- 100 Day34.19
- 300 Day38.75
Hindustan Organic Chemicals Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- India Gelatine And Chemicals
- 361.8
- 1.7
- 0.47
- 449.8
- 306.05
- 256.67
- Kesar Petroproducts
- 25.61
- -0.37
- -1.42
- 32.95
- 14.75
- 247.58
- Hindustan Organic Chemicals
- 36.52
- 0.01
- 0.03
- 62.7
- 22.36
- 245.32
- Arcl Organics
- 285
- -3.5
- -1.21
- 324.55
- 68.47
- 228
- Narmada Gelatines
- 371.7
- 5.6
- 1.53
- 449.4
- 300
- 225.36
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- India Gelatine And Chemicals
- 14.69
- 1.49
- 12.62
- 9.02
- Kesar Petroproducts
- 25.22
- 1.75
- 3.05
- 2.54
- Hindustan Organic Chemicals
- 3.8
- 0.23
- 56.93
- 9
- Arcl Organics
- 18.71
- 2.98
- -
- -
- Narmada Gelatines
- 50.08
- 1.84
- 11.29
- 8.04
Hindustan Organic Chemicals Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 16-May-25
- Audited Results & Reduction of Capital
- 08-Apr-25
- Others
- 12-Feb-25
- Quarterly Results
- 08-Nov-24
- Quarterly Results
- 15-Oct-24
- Others
- 09-Aug-24
- Quarterly Results
- 13-Jun-24
- Others
- 05-Jun-24
- Others
- 22-May-24
- Audited Results
- 09-Feb-24
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 25-Sept-24
- 12-Aug-24
- AGM
- 26-Sept-23
- 10-Aug-23
- AGM
- 10-Jul-23
- 07-Jun-23
- POM
- 13-Mar-23
- 09-Feb-23
- POM



